Mail

UK markets close in 4 hours

FTSE 100
8,147.38
+3.25(+0.04%)
FTSE 250
19,938.36
-27.03(-0.14%)
AIM
764.51
+3.77(+0.50%)
GBP/EUR
1.1694
-0.0014(-0.12%)
GBP/USD
1.2479
-0.0017(-0.13%)
Bitcoin GBP
46,086.06
-3,178.41(-6.45%)

Family finances

Who is the breadwinner in your family and does it matter?

Merit Medical Systems, Inc. (MMSI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

74.10

-0.99

(-1.32%)

At close: 04:00PM EDT

73.98

-0.12

(-0.16%)

After hours:

06:09PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	4.30B
Enterprise value	4.61B
Trailing P/E	45.75
Forward P/E	22.37
PEG ratio (5-yr expected)	1.95
Price/sales (ttm)	3.44
Price/book (mrq)	3.58
Enterprise value/revenue	3.66
Enterprise value/EBITDA	20.13

Trading information

Stock price history

Beta (5Y monthly)	N/A
52-week change ³	-11.14%
S&P500 52-week change ³	23.10%
52-week high ³	85.62
52-week low ³	62.58
50-day moving average ³	74.40
200-day moving average ³	72.53

Share statistics

Avg vol (3-month) ³	396k
Avg vol (10-day) ³	348.73k
Shares outstanding ⁵	58.06M
Implied shares outstanding ⁶	58.06M
Float ⁸	56.56M
% held by insiders ¹	2.44%
% held by institutions ¹	102.62%
Shares short (15 Apr 2024) ⁴	2.06M
Short ratio (15 Apr 2024) ⁴	5.61
Short % of float (15 Apr 2024) ⁴	5.20%
Short % of shares outstanding (15 Apr 2024) ⁴	3.55%
Shares short (prior month 15 Mar 2024) ⁴	2.26M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	5:4
Last split date ³	06 May 2011

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	7.94%
Operating margin (ttm)	11.07%

Management effectiveness

Return on assets (ttm)	4.25%
Return on equity (ttm)	8.45%

Income statement

Revenue (ttm)	1.28B
Revenue per share (ttm)	22.22
Quarterly revenue growth (yoy)	8.70%
Gross profit (ttm)	N/A
EBITDA	229.42M
Net income avi to common (ttm)	101.95M
Diluted EPS (ttm)	1.62
Quarterly earnings growth (yoy)	36.40%

Balance sheet

Total cash (mrq)	581.92M
Total cash per share (mrq)	10.04
Total debt (mrq)	872.75M
Total debt/equity (mrq)	70.37%
Current ratio (mrq)	6.03
Book value per share (mrq)	21.40

Cash flow statement

Operating cash flow (ttm)	166.82M
Levered free cash flow (ttm)	117.02M